Corvus Pharmaceuticals Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
29
IPO date
Mar 23, 2016

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company that tries to turn lab discoveries into new medicines for immune-related diseases and cancer. It does not sell a broad line of approved drugs. Instead, it advances a small group of drug candidates through preclinical work and clinical trials to see whether they are safe and effective enough for approval.

Its main customers are not patients today but rather future buyers in the healthcare system, such as hospitals, doctors, and insurers, if one of its medicines reaches the market. Corvus makes money mainly by funding research and development through capital raises, and, if its drug programs succeed, it could also earn revenue from partnerships, licensing deals, milestone payments, and eventually product sales or royalties.

What makes Corvus different is that it sits at the very early, high-risk end of the drug industry. Its value depends on scientific results, regulatory review, and the ability to move a few lead programs forward, rather than on a large existing product portfolio. That makes it more like a research engine for new therapies than a traditional drug company with steady sales.

Corvus Pharmaceuticals Inc Investor Relations

Address
863 Mitten Rd Ste 102
Burlingame, California
United States of America

Business Segments

Drug development

Corvus Pharmaceuticals develops experimental medicines for cancer and immune-related diseases, then tests them in clinical trials and moves the most promising programs forward.

Customers and revenue model

Management

Dr. Richard A. Miller M.D.

Co-Founder, President, CEO & Chairman of the Board

Biography unavailable

Dr. Peter A. Thompson FACP, M.D.

Co-Founder & Independent Director

Biography unavailable

Mr. Leiv Lea

Chief Financial Officer

Biography unavailable

Dr. William Benton Jones Ph.D.

Senior Vice President of Pharmaceutical Development

Biography unavailable

Dr. James T. Rosenbaum M.D.

Senior Vice President of Research

Biography unavailable

Mr. Jeffrey S. Arcara

Chief Business Officer

Biography unavailable

1 / 6